We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

36 hedge funds and large institutions have $9.35M invested in SQZ Biotechnologies Company in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 48 → 36 (-12)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

72% less capital invested

Capital invested by funds: $33.5M → $9.35M (-$24.1M)

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
36
Holders Change
-12
Holders Change %
-25%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
5
Reduced
9
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
+$1.19M
2
Renaissance Technologies
Renaissance Technologies
New York
+$121K
3
Jane Street
Jane Street
New York
+$93.7K
4
AMG
Advisors Management Group
Wisconsin
+$30.6K
5
HF
HRT Financial
New York
+$28.4K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$2M
2
BlackRock
BlackRock
New York
-$341K
3
E
Ergoteles
New York
-$75.9K
4
DWM
Dakota Wealth Management
Florida
-$46K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
26
HSBC Holdings
United Kingdom
$8.12K – – –
BSB
27
Bangor Savings Bank
Maine
$8K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$7K -$627 -287 -3%
BAM
29
Baldrige Asset Management
Pennsylvania
$4K – – –
Morgan Stanley
30
Morgan Stanley
New York
$2.42K -$22.2K -10,145 -76%
Barclays
31
Barclays
United Kingdom
$1.33K – – –
National Bank of Canada
32
National Bank of Canada
Quebec, Canada
$710 – – –
Wells Fargo
33
Wells Fargo
California
$98 +$9 +4 +3%
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Quebec, Canada
$78 – – –
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$15 +$913 +418 +2%
Citigroup
36
Citigroup
New York
$12 – – –
DWM
37
Dakota Wealth Management
Florida
– -$46K -20,000 Closed
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
– -$40K -17,679 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$38K -16,891 Closed
Two Sigma Investments
40
Two Sigma Investments
New York
– -$31K -13,620 Closed
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
– -$28K -12,404 Closed
EMG
42
ETF Managers Group
New Jersey
– -$20K -8,631 Closed
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
– -$9.68K -4,247 Closed
UBS Group
44
UBS Group
Switzerland
– -$8K -3,337 Closed
JP Morgan Chase
45
JP Morgan Chase
New York
– -$5K -2,075 Closed
TWC
46
TD Waterhouse Canada
Ontario, Canada
– -$3.15K -1,000 Closed
1
2

SQZ Hedge Fund Activity: Q4 2022 in Review

36 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2022, worth a combined $9.35M — down 72% from $33.5M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SQZ and 3 opened new positions — a net loss of 10 holders — while 9 trimmed existing stakes and 5 added.

The largest buyer was Stifel Financial, adding an estimated $1.19M. The largest seller was 683 Capital Management, cutting an estimated $2M.

  • 36 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2022, down from 48 in Q3 2022.
  • Funds reported $9.35M of SQZ Biotechnologies Company stock for Q4 2022, down 72% quarter-over-quarter.
  • 3 funds opened new SQZ Biotechnologies Company positions in Q4 2022 and 13 closed out, a net change of -10 holders.
  • The largest SQZ Biotechnologies Company buyer in Q4 2022 was Stifel Financial, an estimated $1.19M added.
  • The largest SQZ Biotechnologies Company seller in Q4 2022 was 683 Capital Management, an estimated $2M sold.

Based on aggregated 13F filings for Q4 2022.